Skip to content
TrialScanner

NCT01921712

A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients

Phase 1CompletedPULMLead

Registry record

Lead sponsor
Pulmatrix Inc.
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Primary completion
Dec 2013Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01921712 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01921712: A Safety, Pharmacokinetic... | TrialScanner